131 related articles for article (PubMed ID: 23495791)
1. Bacterial lipid modification enhances immunoprophylaxis of filarial abundant larval transcript-2 protein in Mastomys model.
Sharmila S; Christiana I; Kiran P; Reddy MV; Sankaran K; Kaliraj P
Parasite Immunol; 2013 Jul; 35(7-8):201-13. PubMed ID: 23495791
[TBL] [Abstract][Full Text] [Related]
2. The adjuvant-free immunoprotection of recombinant filarial protein Abundant Larval Transcript-2 (ALT-2) in Mastomys coucha and the immunoprophylactic importance of its putative signal sequence.
Sharmila S; Christiana I; Kiran P; Reddy MV; Kaliraj P
Exp Parasitol; 2011 Nov; 129(3):247-53. PubMed ID: 21864531
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis.
Madhumathi J; Prince PR; Rao DN; Karande AA; Reddy MV; Kaliraj P
J Helminthol; 2017 Jan; 91(1):43-54. PubMed ID: 26892175
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.
Ganapathy M; Perumal A; Mohan C; Palaniswamy H; Perumal K
Plant Cell Rep; 2014 Jan; 33(1):179-88. PubMed ID: 24277081
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a multisubunit vaccine considerably reduces establishment of infective larvae in a rodent model of Brugia malayi.
Shrivastava N; Singh PK; Nag JK; Kushwaha S; Misra-Bhattacharya S
Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):507-19. PubMed ID: 23829972
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
[TBL] [Abstract][Full Text] [Related]
7. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.
Joseph SK; Ramaswamy K
Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679
[TBL] [Abstract][Full Text] [Related]
8. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.
Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R
Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Immune Response Elicited by WbALT-2, ALT MAP in Clinical Populations and Mouse Model: A Prophylactic Measure Against Lymphatic Filariasis.
Ramanathan A; Immanuel C; Rao DN; Kaliraj P
Lymphat Res Biol; 2015 Jun; 13(2):120-5. PubMed ID: 26091407
[TBL] [Abstract][Full Text] [Related]
10. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P
Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice.
Anand SB; Murugan V; Prabhu PR; Anandharaman V; Reddy MV; Kaliraj P
Acta Trop; 2008 Aug; 107(2):106-12. PubMed ID: 18547532
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.
Madhumathi J; Prince PR; Anugraha G; Kiran P; Rao DN; Reddy MV; Kaliraj P
Vaccine; 2010 Jul; 28(31):5038-48. PubMed ID: 20653106
[TBL] [Abstract][Full Text] [Related]
13. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.
Gregory WF; Atmadja AK; Allen JE; Maizels RM
Infect Immun; 2000 Jul; 68(7):4174-9. PubMed ID: 10858234
[TBL] [Abstract][Full Text] [Related]
14. Immunoprophylactic evaluation of a 37-kDa Brugia malayi recombinant antigen in lymphatic filariasis.
Dabir P; Dabir S; Krithika KN; Goswami K; Reddy MV
Clin Microbiol Infect; 2006 Apr; 12(4):361-8. PubMed ID: 16524413
[TBL] [Abstract][Full Text] [Related]
15. Structural modelling studies and immunoprophylactic potential of Brugia malayi DEAD Box RNA helicase.
Singh M; Shrivastava N; Saqib U; Siddiqi MI; Misra-Bhattacharya S
Parasitology; 2013 Jul; 140(8):1016-25. PubMed ID: 23743239
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models.
Vedi S; Dangi A; Hajela K; Misra-Bhattacharya S
Vaccine; 2008 Nov; 26(47):5997-6005. PubMed ID: 18817835
[TBL] [Abstract][Full Text] [Related]
17. Multivalent fusion protein vaccine for lymphatic filariasis.
Dakshinamoorthy G; Samykutty AK; Munirathinam G; Reddy MV; Kalyanasundaram R
Vaccine; 2013 Mar; 31(12):1616-22. PubMed ID: 23036503
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.
Dakshinamoorthy G; Kalyanasundaram R
Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Epitope Vaccine from Multistage Antigens for Lymphatic Filariasis.
Anugraha G; Madhumathi J; Prince PR; Prita PJ; Khatri VK; Amdare NP; Reddy MV; Kaliraj P
Scand J Immunol; 2015 Oct; 82(4):380-9. PubMed ID: 26179420
[TBL] [Abstract][Full Text] [Related]
20. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection.
Sahoo MK; Sisodia BS; Dixit S; Joseph SK; Gaur RL; Verma SK; Verma AK; Shasany AK; Dowle AA; Murthy PK
Vaccine; 2009 Jul; 27(32):4263-71. PubMed ID: 19450648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
